G6PD and G6PD deficiency: Therefore, the main objective of this study was to analyse the variations in G6PD activity during P. vivax malaria between day-1 and day-28 after a treatment initiation (chloroquine or artemisinin-based combinations) in order to determine whether early measurements reliably ascertain the absence of G6PD deficiency.